Journal article
Psychological Medicine, vol. 49(12), 2019, pp. 2069-2080
Assistant Professor
519-253-3000 x 2236
401 Sunset Ave., Windsor, ON, N9B 3P4
APA
Click to copy
Ruocco, A. C., Daros, A. R., Chang, J., Rodrigo, A. H., Lam, J., Ledochowski, J., & McMain, S. (2019). Clinical, personality, and neurodevelopmental phenotypes in borderline personality disorder: a family study. Psychological Medicine, 49(12), 2069–2080. https://doi.org/10.1017/S0033291718002908
Chicago/Turabian
Click to copy
Ruocco, A. C., A. R. Daros, J. Chang, A. H. Rodrigo, J. Lam, J. Ledochowski, and S. McMain. “Clinical, Personality, and Neurodevelopmental Phenotypes in Borderline Personality Disorder: a Family Study.” Psychological Medicine 49, no. 12 (2019): 2069–2080.
MLA
Click to copy
Ruocco, A. C., et al. “Clinical, Personality, and Neurodevelopmental Phenotypes in Borderline Personality Disorder: a Family Study.” Psychological Medicine, vol. 49, no. 12, 2019, pp. 2069–80, doi:10.1017/S0033291718002908 .
BibTeX Click to copy
@article{a2019a,
title = {Clinical, personality, and neurodevelopmental phenotypes in borderline personality disorder: a family study},
year = {2019},
issue = {12},
journal = {Psychological Medicine},
pages = {2069-2080},
volume = {49},
doi = {10.1017/S0033291718002908 },
author = {Ruocco, A. C. and Daros, A. R. and Chang, J. and Rodrigo, A. H. and Lam, J. and Ledochowski, J. and McMain, S.}
}
Abstract Background Borderline personality disorder (BPD) is characterized by a heterogeneous clinical phenotype that emerges from interactions among genetic, biological, neurodevelopmental, and psychosocial factors. In the present family study, we evaluated the familial aggregation of key clinical, personality, and neurodevelopmental phenotypes in probands with BPD (n = 103), first-degree biological relatives (n = 74; 43% without a history of psychiatric disorder), and non-psychiatric controls (n = 99). Methods Participants were assessed on DSM-IV psychiatric diagnoses, symptom dimensions of emotion dysregulation and impulsivity, ‘big five’ personality traits, and neurodevelopmental characteristics, as part of a larger family study on neurocognitive, biological, and genetic markers in BPD. Results The most common psychiatric diagnoses in probands and relatives were major depression, substance use disorders, post-traumatic stress disorder, anxiety disorders, and avoidant personality disorder. There was evidence of familial aggregation for specific dimensions of impulsivity and emotion dysregulation, and the big five traits neuroticism and conscientiousness. Both probands and relatives reported an elevated neurodevelopmental history of attentional and behavioral difficulties. Conclusions These results support the validity of negative affectivity- and impulse-spectrum phenotypes associated with BPD and its familial risk. Further research is needed to investigate the aggregation of neurocognitive, neural and genetic factors in families with BPD and their associations with core phenotypes underlying the disorder.